The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHILLION PHARMACEUTICALS IN | COM | 00448Q201 | 1,079 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 2,266 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 2,207 | 34,000 | SH | SOLE | 34,000 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 6,289 | 32,969 | SH | SOLE | 32,969 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 6,939 | 87,415 | SH | SOLE | 87,415 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 4,728 | 50,222 | SH | SOLE | 50,222 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 5,807 | 35,773 | SH | SOLE | 35,773 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 1,667 | 49,100 | SH | SOLE | 49,100 | 0 | 0 | ||
AXOVANT SCIENCES LTD | COM | G0750W104 | 340 | 18,852 | SH | SOLE | 18,852 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 1,032 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 3,211 | 10,482 | SH | SOLE | 10,482 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 4,596 | 43,870 | SH | SOLE | 43,870 | 0 | 0 | ||
BRISTOL MYERS SQUIBB CO | COM | 110122108 | 5,304 | 77,100 | SH | SOLE | 77,100 | 0 | 0 | ||
NOVAVAX INC | COM | 670002104 | 839 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
CARBYLAN THERAPEUTICS INC | COM | 141384107 | 63 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 5,743 | 47,956 | SH | SOLE | 47,956 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 1,750 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 1,187 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
DIPEXIUM PHARMACEUTICALS INC | COM | 25456J104 | 280 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 2,173 | 135,627 | SH | SOLE | 135,627 | 0 | 0 | ||
FLAMEL TECHNOLOGIES SA | SPONSORED ADR | 338488109 | 693 | 56,788 | SH | SOLE | 56,788 | 0 | 0 | ||
FLUIDIGM CORP DEL | COM | 34385P108 | 757 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 3,410 | 33,700 | SH | SOLE | 33,700 | 0 | 0 | ||
HOLOGIC INC | COM | 436440101 | 1,857 | 48,000 | SH | SOLE | 48,000 | 0 | 0 | ||
IGNYTA INC | COM | 451731103 | 1,340 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 4,346 | 22,643 | SH | SOLE | 22,643 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 5,210 | 48,045 | SH | SOLE | 48,045 | 0 | 0 | ||
INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 236 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 6,345 | 102,459 | SH | SOLE | 102,459 | 0 | 0 | ||
ISHARES TR | NASDQ BIOTEC ETF | 464287556 | 10,691 | 31,600 | SH | SOLE | 31,600 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 795 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
LOXO ONCOLOGY INC | COM | 548862101 | 1,707 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 929 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
MEDICINES CO | COM | 584688105 | 934 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
MEDIVATION INC | COM | 58501N101 | 4,414 | 91,310 | SH | SOLE | 91,310 | 0 | 0 | ||
MERCK & CO INC NEW | COM | 58933Y105 | 4,754 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
MERRIMACK PHARMACEUTICALS IN | COM | 590328100 | 968 | 122,500 | SH | SOLE | 122,500 | 0 | 0 | ||
METTLER TOLEDO INTERNATIONAL | COM | 592688105 | 3,290 | 9,700 | SH | SOLE | 9,700 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 1,503 | 102,200 | SH | SOLE | 102,200 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 5,874 | 348,583 | SH | SOLE | 348,583 | 0 | 0 | ||
OPHTHOTECH CORP | COM | 683745103 | 1,335 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
PACIRA PHARMACEUTICALS INC | COM | 695127100 | 1,467 | 19,110 | SH | SOLE | 19,110 | 0 | 0 | ||
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 1,138 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
PRONAI THERAPEUTICS INC | COM | 74346L101 | 451 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
PROSHARES TR | PSHS ULT NASB | 74347R214 | 1,067 | 14,919 | SH | SOLE | 14,919 | 0 | 0 | ||
NOVAVAX INC | COM | 670002104 | 839 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
QIAGEN NV | REG SHS | N72482107 | 4,424 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 5,816 | 10,714 | SH | SOLE | 10,714 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 5,704 | 127,088 | SH | SOLE | 127,088 | 0 | 0 | ||
SERES THERAPEUTICS INC | COM | 81750R102 | 1,158 | 33,000 | SH | SOLE | 33,000 | 0 | 0 | ||
TOKAI PHARMACEUTICALS INC | COM | 88907J107 | 541 | 62,007 | SH | SOLE | 62,007 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 1,020 | 6,514 | SH | SOLE | 6,514 | 0 | 0 | ||
VERICEL CORP | COM | 92346J108 | 857 | 332,157 | SH | SOLE | 332,157 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 5,242 | 41,662 | SH | SOLE | 41,662 | 0 | 0 | ||
REPROS THERAPEUTICS INC | *W EXP 02/08/201 | 76028H126 | 33 | 98,000 | SH | Call | SOLE | 98,000 | 0 | 0 | |
XENCOR INC | COM | 98401F105 | 1,316 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 1,411 | 95,700 | SH | SOLE | 95,700 | 0 | 0 |